Related Posts
- Vision Issues in Belantamab-Treated Myeloma Patients
KEY TAKEAWAYS The BelaRd phase I/II trial aimed to assess ocular side effects and their…
- Managing CRS In RRMM Patients Treated With Teclistamab
KEY TAKEAWAYS This study provided nurses with guidelines for handling CRS in pts treated with…
- CLL Risk: Second Malignancies in Treated vs Untreated Patients
KEY TAKEAWAYS The study aimed to investigate the temporal patterns, frequency, and types of SPMs…